BZPEERReading, trust and collaboration for researchDiscover
Workspaces
Network
Opportunities
Account
Researcher profile
Siddhartha P. Chakrabarty contributes to research discovery and scholarly infrastructure.
Trust snapshot
Actions
Identity and collaboration
Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.
Log in to claimDirect collaboration
Claim this author entity first to unlock direct invitations.
Research graph
Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.
BZPEER is loading the nearby papers, people, topics and institutions for this page.
Published work
This paper empirically analyzes a dataset published by the European Banking Authority. Our main aim was to study how the Leverage Ratio is affected by adverse financial scenarios. This was be followed by observing how Leverage Ratio exposures are correlated to various other financial variables and how various regression techniques can be used to explain the correlation.
In the new paradigm of health-centric governance, policy makers are in a constant need for appropriate metrics and estimates in order to determine the best policies in a non-arbitrary fashion. Thus, in this paper, a compartmentalized model for the transmission of COVID-19 is developed to facilitate policy making. A socially distanced compartment is added to the model and its utility in quantifying the magnitude of voluntary social distancing is illustrated. Modifications are made to incorporate inter-region migration, and suitable metrics are proposed to quantify the impact of migration on the rise of cases. The healthcare capacity is modeled and a method is developed to study the consequences of the saturation of the healthcare system. The model and related measures are used to study the nature of the transmission and spread of COVID-19 in India, and appropriate insights are drawn.
In this paper, we propose and analyze a novel combination of multilevel Richardson-Romberg (ML2R) and importance sampling algorithm, with the aim of reducing the overall computational time, while achieving desired root-mean-squared error while pricing. We develop an idea to construct the Monte-Carlo estimator that deals with the parametric change of measure. We rely on the Robbins-Monro algorithm with projection, in order to approximate optimal change of measure parameter, for various levels of resolution in our multilevel algorithm. Furthermore, we propose incorporating discretization schemes with higher-order strong convergence, in order to simulate the underlying stochastic differential equations (SDEs) thereby achieving better accuracy. In order to do so, we study the Central Limit Theorem for the general multilevel algorithm. Further, we study the asymptotic behavior of our estimator, thereby proving the Strong Law of Large Numbers. Finally, we present numerical results to substantiate the efficacy of our developed algorithm.
We present a three-stage probabilistic model for the progression of Chronic Myeloid Leukemia (CML), as manifested by the leukemic stem cells, progenitor cells and mature leukemic cells. This progression is captured through the process of cell division and cell mutation, with probabilities of occurrence being assigned to both of them. The key contributions of this study include, the determination of the expected number of the leukemic stem cells, progenitor cells, mature leukemic cells, as well as total number of these cells (in terms of probabilities, and contingent on the initial cell count), expected time to reach a threshold level of total and injurious leukemic cells, as well as the critical time when the disease changes its phases, the probability of extinction of CML, and the dynamics of CML evolution consequent to primary therapy. Finally, the results obtained are demonstrated with numerical illustrations.
Although there is a growing consensus that a low-carbon transition will be necessary to mitigate the accelerated climate change, the magnitude of transition-risk for investors is difficult to measure exactly. Investors are therefore constrained by the unavailability of suitable measures to quantify the magnitude of the risk and are forced to use the likes of absolute emissions data or ESG scores in order to manage their portfolios. In this article, we define the Single Event Transition Risk (SETR) and illustrate how it can be used to approximate the magnitude of the total exposure of the price of a share to low-carbon transition. We also discuss potential applications of the single event framework and the SETR as a risk measure and discuss future direction on how this can be extended to a system with multiple transition events.
Chronic Myeloid Leukemia (CML) is a biphasic malignant clonal disorder that progresses, first with a chronic phase, where the cells have enhanced proliferation only, and then to a blast phase, where the cells have the ability of self-renewal. It is well-recognized that the Philadelphia chromosome (which contains the BCR-ABL fusion gene) is the "hallmark of CML". However, empirical studies have shown that the mere presence of BCR-ABL may not be a sufficient condition for the development of CML, and further modifications related to tumor suppressors may be necessary. Accordingly, we develop a three-mutation stochastic model of CML progression, with the three stages corresponding to the non-malignant cells with BCR-ABL presence, the malignant cells in the chronic phase and the malignant cells in the blast phase. We demonstrate that the model predictions agree with age incidence data from the United States. Finally, we develop a framework for the retrospective estimation of the time of onset of malignancy, from the time of detection of the cancer.
In order to analyze the effectiveness of three successive nationwide lockdown enforced in India, we present a data-driven analysis of four key parameters, reducing the transmission rate, restraining the growth rate, flattening the epidemic curve and improving the health care system. These were quantified by the consideration of four different metrics, namely, reproduction rate, growth rate, doubling time and death to recovery ratio. The incidence data of the COVID-19 (during the period of 2nd March 2020 to 31st May 2020) outbreak in India was analyzed for the best fit to the epidemic curve, making use of the exponential growth, the maximum likelihood estimation, sequential Bayesian method and estimation of time-dependent reproduction. The best fit (based on the data considered) was for the time-dependent approach. Accordingly, this approach was used to assess the impact on the effective reproduction rate. The period of pre-lockdown to the end of lockdown 3, saw a $45\%$ reduction in the rate of effective reproduction rate. During the same period the growth rate reduced from $393\%$ during the pre-lockdown to $33\%$ after lockdown 3, accompanied by the average doubling time increasing form $4$-$6$ days to $12$-$14$ days. Finally, the death-to-recovery ratio dropped from $0.28$ (pre-lockdown) to $0.08$ after lockdown 3. In conclusion, all the four metrics considered to assess the effectiveness of the lockdown, exhibited significant favourable changes, from the pre-lockdown period to the end of lockdown 3. Analysis of the data in the post-lockdown period with these metrics will provide greater clarity with regards to the extent of the success of the lockdown.
We propose deterministic and stochastic models for studying the pharmacokinetics of chronic myeloid leukemia (CML), upon administration of IFN-$α$ (the traditional treatment for CML), TKI (the current frontline medication for CML) and Wnt/$β$-catenin signaling (the state-of-the art therapeutic breakthrough for CML). To the best of our knowledge, no mathematical model incorporating all these three therapeutic protocols are available in literature. Further, this work introduces a stochastic approach in the study of CML dynamics. The key contributions of this work are: (1) Determination of the patient condition, contingent upon the patient specific model parameters, which leads to prediction of the appropriate patient specific therapeutic dosage. (2) Addressing the question of how the dual therapy of TKI and Wnt/$β$-catenin signaling or triple combination of all three, offers potentially improved therapeutic responses, particularly in terms of reduced side effects of TKI or IFN-$α$. (3) Prediction of the likelihood of CML extinction/remission based on the level of CML stem cells at detection.
We examine two models for hepatitis C viral (HCV) dynamics, one for monotherapy with interferon (IFN) and the other for combination therapy with IFN and ribavirin. Optimal therapy for both the models is determined using the steepest gradient method, by defining an objective functional which minimizes the infected hepatocyte levels, virion population and the side-effects of the drug(s). The optimal therapy for both the models shows an initial period of high efficacy, followed by a gradual decline. The period of high efficacy coincides with a significant decrease in the infected hepatocyte levels as well as viral load, whereas the efficacy drops after liver regeneration through restored hepatocyte levels. The period of high efficacy is not altered significantly when the cost coefficients are varied, as long as the side effects are relatively small. This suggests a higher dependence of the optimal therapy on the model parameters in case of drugs with minimal side effects. We use the Latin hypercube sampling technique to randomly generate a large number of patient scenarios (i.e, model parameter sets) and study the dynamics of each set under the optimal therapy already determined. Results show an increase in the percentage of responders (as indicated by drop in viral load below detection levels) in case of combination therapy as compared to monotherapy. Statistical tests performed to study the correlations between sample parameters and the time required for the viral load to fall below detection level, show a strong monotonic correlation with the death rate of infected hepatocytes, identifying it to be an important factor in deciding individual drug regimens.
In this paper, a standard PDE for the pricing of arithmetic average strike Asian call option is presented. A Crank-Nicolson Implicit Method and a Higher Order Compact finite difference scheme for this pricing problem is derived. Both these schemes were implemented for various values of risk free rate and volatility. The option prices for the same set of values of risk free rate and volatility was also computed using Monte Carlo simulation. The comparative results of the two numerical PDE methods shows close match with the Monte Carlo results, with the Higher Order Compact scheme exhibiting a better match. To the best of our knowledge, this is the first work to use the numerical PDE approach for pricing Asian call options with average strike.